Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,354,998 papers from all fields of science
Search
Sign In
Create Free Account
Melphalan 50 MG Injection [Evomela]
Known as:
Evomela 50 MG (equivalent to 56 MG melphalan HCl) Injection
, Evomela 50 MG Injection
, MELPHALAN HYDROCHLORIDE 50 mg in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EVOMELA]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Evomela
Injection
Melphalan
Melphalan hydrochloride
Expand
Broader (1)
Melphalan Injection [Evomela]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effect of Melphalan Exposure in Patients with Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)
A. Lin
,
P. Dahi
,
+16 authors
G. Shah
2020
Corpus ID: 213852941
2020
2020
CLO20-049: Retrospective Study of Safety and Toxicity Profile Comparison for Propylene Glycol-Free Melphalan (Evomela®) and Generic Melphalan
K. Maung
,
N. Chao
,
+11 authors
T. Choi
2020
Corpus ID: 216302262
2019
2019
Toxicity Analysis of Propylene Glycol-Free Melphalan (Evomela®) Compared to Propylene Glycol-Based Melphalan Hydrochloride in Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Lauren DeRespiris
,
V. Bhatt
,
+6 authors
G. Shah
Biology of Blood and Marrow Transplantation
2019
Corpus ID: 86560577
2019
2019
Successful Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic…
G. Shah
,
A. Lin
,
+12 authors
H. Landau
Clinical Lymphoma, Myeloma & Leukemia
2019
Corpus ID: 208482163
Review
2018
Review
2018
Safety and Efficacy of Evomela™ in Myeloma Autotransplants
Kimberly V Amelsberg
,
Nisha S. Joseph
,
+9 authors
A. Nooka
Blood
2018
Corpus ID: 208372379
Background: High-dose chemotherapy followed by autologous stem cell transplantation (SCT) is the current standard of care for…
Expand
2018
2018
Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid…
G. Shah
,
H. Landau
,
+18 authors
S. Giralt
2018
Corpus ID: 80011073
2018
2018
Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing…
G. Shah
,
A. Lin
,
+15 authors
H. Landau
2018
Corpus ID: 57680242
2017
2017
Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis
G. Shah
,
H. Landau
,
+11 authors
S. Giralt
2017
Corpus ID: 201167231
Background: Melphalan exposure as measured by area under the curve (AUC) has a 5-fold variability between patients, with higher…
Expand
Review
2017
Review
2017
Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients…
G. Shah
,
A. Lin
,
+13 authors
H. Landau
2017
Corpus ID: 203338388
Background: For multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant…
Expand
Review
2016
Review
2016
Propylene glycol-free melphalan as conditioning regimen for autologous transplantation in myeloma.
O. Aljitawi
,
P. Hari
International Journal of Hematologic Oncology
2016
Corpus ID: 52944765
High-dose melphalan has been the drug of choice for preparative regimens for autologous stem cell transplantation in multiple…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE